Sergio Reyes

542 total citations
13 papers, 224 citations indexed

About

Sergio Reyes is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Pharmacology. According to data from OpenAlex, Sergio Reyes has authored 13 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Applied Microbiology and Biotechnology, 7 papers in Molecular Medicine and 5 papers in Pharmacology. Recurrent topics in Sergio Reyes's work include Antibiotic Use and Resistance (8 papers), Antibiotic Resistance in Bacteria (7 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Sergio Reyes is often cited by papers focused on Antibiotic Use and Resistance (8 papers), Antibiotic Resistance in Bacteria (7 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Sergio Reyes collaborates with scholars based in United States, Colombia and Spain. Sergio Reyes's co-authors include María Virginia Villegas, Kevin Escandón-Vargas, Sergio Gutiérrez, David P. Nicolau, Kamilia Abdelraouf, Pranita D. Tamma, Audrey N. Schuetz, Cristhian Hernández-Gómez, Joseph L. Kuti and Christian Pallares and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy and Clinical Therapeutics.

In The Last Decade

Sergio Reyes

13 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sergio Reyes United States	8	177	102	82	54	37	13	224
Cristhian Hernández-Gómez Colombia	8	175 1.0×	99 1.0×	57 0.7×	67 1.2×	39 1.1×	20	231
R. Andini Italy	4	187 1.1×	67 0.7×	84 1.0×	48 0.9×	56 1.5×	5	238
Ngai Kien Le Vietnam	8	164 0.9×	76 0.7×	56 0.7×	53 1.0×	63 1.7×	10	253
Christopher Blunden United States	5	172 1.0×	93 0.9×	74 0.9×	40 0.7×	64 1.7×	7	240
Maria Souli Greece	2	183 1.0×	66 0.6×	51 0.6×	66 1.2×	46 1.2×	5	204
Evangelos Vryonis Greece	7	190 1.1×	67 0.7×	100 1.2×	59 1.1×	80 2.2×	11	300
Juan José Maya Colombia	6	166 0.9×	73 0.7×	35 0.4×	58 1.1×	35 0.9×	8	215
Silvio Vega Panama	6	161 0.9×	121 1.2×	57 0.7×	37 0.7×	54 1.5×	13	273
Francisco Moreno-Ramos Spain	9	205 1.2×	148 1.5×	106 1.3×	73 1.4×	88 2.4×	21	334
Sandra Yamile Saavedra Colombia	8	155 0.9×	56 0.5×	29 0.4×	62 1.1×	39 1.1×	17	202

Countries citing papers authored by Sergio Reyes

Since Specialization

Citations

This map shows the geographic impact of Sergio Reyes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Reyes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Reyes more than expected).

Fields of papers citing papers by Sergio Reyes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Reyes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Reyes. The network helps show where Sergio Reyes may publish in the future.

Co-authorship network of co-authors of Sergio Reyes

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Reyes. A scholar is included among the top collaborators of Sergio Reyes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Reyes. Sergio Reyes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Pallares, Christian, Cristhian Hernández-Gómez, Kevin Escandón-Vargas, et al.. (2022). Impact of antimicrobial stewardship programs on antibiotic consumption and antimicrobial resistance in four Colombian healthcare institutions. BMC Infectious Diseases. 22(1). 420–420. 15 indexed citations

Abdelraouf, Kamilia, Sergio Reyes, & David P. Nicolau. (2020). The paradoxical in vivo activity of β-lactams against metallo-β-lactamase-producing Enterobacterales is not restricted to carbapenems. Journal of Antimicrobial Chemotherapy. 76(3). 684–691. 12 indexed citations

Reyes, Sergio, Kamilia Abdelraouf, & David P. Nicolau. (2020). In vivo activity of human-simulated regimens of imipenem alone and in combination with relebactam against Pseudomonas aeruginosa in the murine thigh infection model. Journal of Antimicrobial Chemotherapy. 75(8). 2197–2205. 18 indexed citations

Reyes, Sergio & David P. Nicolau. (2020). Precision medicine for the diagnosis and treatment of carbapenem-resistant Enterobacterales: time to think from a different perspective. Expert Review of Anti-infective Therapy. 18(8). 721–740. 15 indexed citations

Ordóñez, Karen, et al.. (2019). Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia. The Brazilian Journal of Infectious Diseases. 23(4). 237–245. 5 indexed citations

Blanco, V. M., Marta Vallejo, Cristhian Hernández-Gómez, et al.. (2019). Impacto clínico del desescalamiento a ertapenem en pacientes críticos con infecciones por Enterobacteriaceae. Revista chilena de infectología. 36(1). 9–15. 2 indexed citations

Avery, Lindsay M., et al.. (2019). Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration. Clinical Therapeutics. 41(10). 2162–2170. 8 indexed citations

Reyes, Sergio, et al.. (2018). [Risk factors and clinical evolution of carbapenemase-producing Klebsiella pneumoniae infections in a university hospital in Spain. Case-control study].. PubMed. 31(5). 427–434. 6 indexed citations

Hernández-Gómez, Cristhian, Christian Pallares, Sergio Reyes, et al.. (2017). Clinical Impact of Antimicrobial Stewardship Programs in Colombian Acute Care Hospitals. Open Forum Infectious Diseases. 4(suppl_1). S486–S487. 2 indexed citations

10.

Schuetz, Audrey N., Sergio Reyes, & Pranita D. Tamma. (2017). Point-Counterpoint: Piperacillin-Tazobactam Should Be Used To Treat Infections with Extended-Spectrum-Beta-Lactamase-Positive Organisms. Journal of Clinical Microbiology. 56(3). 26 indexed citations

11.

Hernández-Gómez, Cristhian, Christian Pallares, Kevin Escandón-Vargas, et al.. (2016). Economic Impact of an Antimicrobial Stewardship Program Implementation in Three High-Complexity Hospitals in Colombia. Open Forum Infectious Diseases. 3(suppl_1). 3 indexed citations

12.

Escandón-Vargas, Kevin, Sergio Reyes, Sergio Gutiérrez, & María Virginia Villegas. (2016). The epidemiology of carbapenemases in Latin America and the Caribbean. Expert Review of Anti-infective Therapy. 15(3). 277–297. 97 indexed citations

13.

García, Patricia, et al.. (2012). Primer caso de detección de blaKpc en Chile: desde Italia a un hospital público de Santiago. Revista chilena de infectología. 29(2). 224–228. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact